CLC Number: 

  • R711.74
[1] Williams C, Petignat P, Belisle A. Primary abdominal wall clear cell carcinoma: case report and review of literature[J].Anticancer research, 2009, 29(5):1591-1593.
[2] Monist M, Lewkowicz D, Józwik M, et al.Atypical endometrial hyperplasia arising in a cesarean section scar: a mechanism of malignant transformation[J].Case reports in oncology, 2019, 12(1):317-321.
[3] Saavalainen L, Lassus H, But A, et al. Risk of gynecologic cancer according to the type of endometriosis[J].Obstet gynecol, 2018, 131(6):1095-1102.
[4] Kobayashi H.Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis[J].Int J Clin Oncol, 2009,14(5):378-382.
[5] Modesitt SC, Tortolero-Luna G, Robinson JB, et al.Ovarian and extraovarian endometriosis-associated cancer[J].Obstet Gynecol, 2002,100(4):788-795.
[6] Krawczyk N, Banys-Paluchowski M, Schmidt D, et al.Endometriosis-associated malignancy[J].Geburtshilfe Frauenheilkd, 2016, 76(2):176-181.
[7] Gentile JKA, Migliore R, Kistenmacker FJN, et al.Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report[J]. Sao Paulo Med J, 2018, 136(6):586-590.
[8] Lai YL, Hsu HC, Kuo KT, et al. Clear Cell carcinoma of the abdominal wall as a rare complication of general obstetric and gynecologic surgeries: 15 years of experience at a large academic institution[J]. Int J Environ Res Public Health, 2019, 16(4). doi: 10.3390/ijerph16040552.
[9] Taburiaux L, Pluchino N, Petignat P. Endometriosis-associated abdominal wall cancer: a poor prognosis?[J]. Int J Gynecol Cancer, 2015, 25(9):1633-1638.
[10] Heller DS, Houck K, Lee ES. Clear cell adenocarcinoma of the abdominal wall: a case report[J]. J Reprod Med, 2014, 59(5-6):330-332.
[11] Rivera Rolon MDM, Allen D, Richardson G.Abdominal Wall Clear Cell Carcinoma: Case Report of a Rare Event with Potential Diagnostic Difficulties[J]. Case Rep Pathol 2019, 2019:1695734. doi: 10.1155/2019/1695734.
[12] Ferrandina G, Palluzzi E, Fanfani F, et al.Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature[J]. World J Surg Oncol, 2016, 14(1):300.
[13] Mihailovici A, Rottenstreich M, Kovel S, et al.Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review[J]. Medicine(Baltimore), 2017, 96(49):e9136. doi: 10.1097/MD.0000000000009136.
[14] Ruiz MP, Wallace DL. Transformation of abdominal wall endometriosis to clear cell carcinoma[J]. Case Rep Obstet Gynecol, 2015: 123740. doi: 10.1155/2015/123740.
[15] Matsuo K, Alonsozana EL, Eno ML, et al.Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery[J]. Arch Gynecol Obstet, 2009, 280(4):637-641.
[16] Horton JD, Dezee KJ, Ahnfeldt EP. Abdominal wall endometriosis: a surgeons perspective and review of 445 cases[J]. Am J Surg, 2008, 196(2):207-212.
[17] 彭靖淇, 张静, 金武勇, 等. 复合补片修补腹壁肿瘤切除后巨大腹壁缺损的临床疗效[J].中华疝和腹壁外科杂志(电子版), 2019, 13(4):335-338.
[1] . [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 125-128.
[2] Guowei TAO,Fang WANG,Xiangyi DONG,Yaxuan XU,Linli ZHAO,Beibei HU. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65.
[3] Guoyun WANG,Zangyu PAN. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55.
[4] Lei YAN,Zijiang CHEN. Treatment of adenomyosis complicated with infertility [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 43-47.
[5] AILI Aixingzi,Zhengyu GUO,Xiaofei ZHANG. Latest research advances of high intensity focused ultrasound treatment for adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 36-42.
[6] Xiaofang YI,Jihua HUANG. Patient education and proper management of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 32-35.
[7] Xinmei ZHANG,Ping XU. Surgical treatment strategies of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 26-31.
[8] Chao PENG,Yingfang ZHOU. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[9] Sunwei GUO,Xishi LIU. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19.
[10] Jinhua LENG,Jinghua SHI. Clinical manifestations of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 1-5.
[11] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 93-94.
[12] LU Zhenzhen, YAN Lei, ZHANG Hui, ZHANG Xiaohui, ZHAO Xingbo. Effects of TGF β-1 on the activation of endometrial stromal cells in tumor microenvironment [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 37-40.
[13] ZHANG Xiaohui, YAN Lei, QI Shasha, LU Zhenzhen, LI Mingjiang, ZHAO Xingbo. Occurrence of epithelia-mesenchymal transition in endometrial adenocarci-noma and the roles of miR200a/ZEB1 signaling pathway in this process [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 48-52.
[14] LIU Jian-meng, CUI Bao-xia, YIN Ting, ZHANG Ai-rong. Expression and significance of pigment epithelium-derived
factor in cervix squamous cell carcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 103-106.
[15] SU Shan1, KAN Yanyan1, TIAN Yongjie2. Expressions and significances of sFRP-1 and Wnt-1 in cervical carcinoma and precancerous lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 97-101.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!